Corrigendum to “iPSC modeling of rare pediatric disorders” [J. Neurosci. Methods 332 (15) (2020) 108533] (Journal of Neuroscience Methods (2020) 332, (S0165027019303905), (10.1016/j.jneumeth.2019.108533))

During the revision process, two references were inadvertently excluded from the manuscript. References 108 and 109 within the manuscript should refer to the following publications: 108. Wassif, C.A., Zhu, P., Kratz, L., Krakowiak, P.A., Battaile, K.P., Weight, F.F., Grinberg, A., Steiner, R.D., Nwokoro, N.A., Kelley, R.I. et al. (2001) Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith–Lemli–Opitz syndrome. Hum. Mol. Genet., 10, 555–564. 109. Fitzky, B.U., Moebius, F.F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., Maeda, N., Kluckman, K., Hiller, S., Yu, H. et al. (2001) 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith–Lemli–Opitz/RSH syndrome. J. Clin. Invest., 108, 905–915. Additionally, reference 42 was inadvertently included on Page 6 during discussion of LIF/JAK/STAT signalling. The authors would like to apologize for any inconvenience caused.